BioSpace: Biotech, Pharmaceutical and Clinical Research News
2010年12月11日 · 2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts …
News - BioSpace
In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of its Ionis-partnered therapy Spinraza for spinal muscular …
Regeneron Acquisition of Oxular Wipes Out Oxular Workforce
2025年1月3日 · 2024 was a tough year for the biopharma industry, with several companies including Bayer, Bristol Myers Squibb and Johnson & Johnson are cutting hundreds or even …
7 Indications for GLP-1s Beyond Weight Loss - BioSpace
2024年12月23日 · Last month, a real-world study linked Novo’s semaglutide with a 40% to 70% drop in the risk of Alzheimer’s disease in patients with type 2 diabetes, versus treatment with …
FDA Committee Calls For More Research After Moderna’s RSV …
2024年12月13日 · The FDA on Tuesday revealed that it has detected severe side effects in two of Moderna ’s experimental mRNA-based respiratory syncytial vaccine candidates, which the …
HEK 293 Cells: Background, Advantages and Applications
2021年6月18日 · Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are quite popular because …
Approvals - BioSpace
2025年1月16日 · The Phase III CodeBreaK 300 study returned disappointing overall survival data for Lumakras plus Vectibix in metastatic colorectal cancer, but in its approval announcement, …
Phase III Clinical Trials - BioSpace
2025年1月17日 · The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which exceeded the consensus by a modest 1% …
Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval
2024年12月23日 · Eli Lilly’s weight loss blockbuster has snagged the first ever FDA drug approval for obstructive sleep apnea. The expanded indication announcement sent the company’s stock …
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market
2024年11月21日 · Ahead of its investor event Thursday, Novartis revealed it is acquiring California-based biotech Kate Therapeutics, a move that “compliments” the pharma’s push to …